- Home
- TATT vs AUTL Comparison
TATT vs AUTL Comparison
Compare TATT & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TATT
- AUTL
- Stock Information
- Founded
- TATT 1985
- AUTL 2014
- Country
- TATT Israel
- AUTL United Kingdom
- Employees
- TATT N/A
- AUTL N/A
- Industry
- TATT Aerospace
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TATT Industrials
- AUTL Health Care
- Exchange
- TATT Nasdaq
- AUTL Nasdaq
- Market Cap
- TATT 308.2M
- AUTL 360.6M
- IPO Year
- TATT 1987
- AUTL 2018
- Fundamental
- Price
- TATT $32.84
- AUTL $1.43
- Analyst Decision
- TATT Strong Buy
- AUTL Strong Buy
- Analyst Count
- TATT 1
- AUTL 5
- Target Price
- TATT $35.00
- AUTL $9.32
- AVG Volume (30 Days)
- TATT 133.9K
- AUTL 1.8M
- Earning Date
- TATT 05-21-2025
- AUTL 05-13-2025
- Dividend Yield
- TATT N/A
- AUTL N/A
- EPS Growth
- TATT 96.08
- AUTL N/A
- EPS
- TATT 1.00
- AUTL N/A
- Revenue
- TATT $152,116,000.00
- AUTL $10,120,000.00
- Revenue This Year
- TATT $18.62
- AUTL $277.74
- Revenue Next Year
- TATT $10.62
- AUTL $221.89
- P/E Ratio
- TATT $32.84
- AUTL N/A
- Revenue Growth
- TATT 33.68
- AUTL 496.00
- 52 Week Low
- TATT $11.01
- AUTL $1.11
- 52 Week High
- TATT $33.37
- AUTL $5.25
- Technical
- Relative Strength Index (RSI)
- TATT 74.59
- AUTL 45.37
- Support Level
- TATT $28.07
- AUTL $1.32
- Resistance Level
- TATT $29.49
- AUTL $1.45
- Average True Range (ATR)
- TATT 1.98
- AUTL 0.16
- MACD
- TATT 0.53
- AUTL 0.02
- Stochastic Oscillator
- TATT 89.97
- AUTL 61.90
About TATT TAT Technologies Ltd.
TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.